News – Page 56 – Endpoints News

Roche's cardiometabolic chief warns against weight loss 'obsession' with GLP-1s

4 months ago

Departing FDA commissioner: 'We're losing the battle on misinformation'

4 months ago

Teva says it has a 'unique position' in latest IRA challenge

4 months ago

HHS blasts Boehringer's drug price case, reveals new details on Jardiance talks

4 months ago

Shionogi lands $375M from HHS to develop preventive drug for Covid-19

4 months ago

DC appeals court halts launch of generic to Novartis' heart drug

4 months ago

EMA in 2024 recommended highest number of drug approvals in 15 years

4 months ago

Is digital health living up to its promise?

4 months ago

In first earnings since top exec’s murder, UnitedHealth Group diverts blame for healthcare frustrations

4 months ago

Novartis enters fight against HHS for denying its 340B rebate model

4 months ago

Broad Institute paper offers potential new framework for treating Huntington’s disease

4 months ago

Boehringer's schizophrenia asset fails Phase 3; GSK buys organoid biotech

4 months ago

Denmark’s new manufacturing learning center; Telix buys facility, assets and tech from ImaginAb

4 months ago

FDA rejects Atara's cell therapy for rare transplant complication, stock craters

4 months ago

A mixed year for deals and dollars left biotech execs hungry for a better 2025

4 months ago

Vaccine patch startup collects an additional $16M to Series A

4 months ago

Eli Lilly's Omvoh earns FDA approval for Crohn's disease

4 months ago

DEA issues proposed rule to permanently expand online prescribing of controlled substances

4 months ago

Vertex's bid to offer Casgevy fertility support is 'self-serving,' HHS says

4 months ago

FDA explains why it rejected Vanda's stomach drug in late 2024

4 months ago

Drugmakers tout limits of IRA impact ahead of next negotiation round

4 months ago

Hinge Bio's $30M raise; Keros reports additional issues in Phase 2 PAH trial

4 months ago

Oncology biotech plots expedited approval for bone cancer drug after Phase 2 win

4 months ago

#JPM25 live blog day 3: PhRMA chief on reforming the IRA; Gilead weighs in on China dealmaking

4 months ago

First page Previous page 53 54 555657 58 59 Next page Last page